University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) — Los Angeles, California

University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) is a clinical research site located in Los Angeles, California, United States 90038.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) has participated in 1 clinical trials.

Therapeutic areas: Methamphetamine Use Disorder.

Sponsors: University of Texas Southwestern Medical Center.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)?

University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) conducted?

University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) has 1 clinical trials on record. Their work covers Methamphetamine Use Disorder.

Is University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) accredited by Crixeo Health?

University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.